EUVIMEDEUVIMED entdecken
Open Access

Mitochondrial OXPHOS restricts SARS-CoV-2 replication

Yentli E Soto Albrecht iD, Ryan M Morrow, Devin Kenney iD, Arnold Z Olali iD, Alan Wacquiez iD, Nader Chehadeh iD, Zimu Cen iD, Jeffrey A Haltom, Ian Chen iD, Sujata S Ranshing, Gabrielle A Widjaja iD, Alessia Angelin iD und 10 weitere

Science Advances · 05.06.2026 · 12 (23)

DOI: 10.1126/sciadv.adz3081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 05.06.2026. Verfasst von Yentli E Soto Albrecht und 21 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Virus Replication, Oxidative Phosphorylation, Mitochondria, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rewires host metabolism to optimize virus production. Although glycolysis is necessary for virus production, the importance of mitochondrial oxidative phosphorylation (OXPHOS) is unknown. The mitochondrial DNA (mtDNA) codes for 13 critical OXPHOS polypeptides plus the 22 transfer RNAs (tRNAs) and 2 ribosomal RNAs (rRNAs) for mitochondrial protein synthesis. We found an ∼5- to 100-fold greater SARS-CoV-2 virus production in infected human ACE2-expressing A549 lung cells when OXPHOS was inhibited by mtDNA depletion (ρ 0 cells), inhibition of mitochondrial translation with chloramphenicol (CAP), or chemical inhibition of OXPHOS complexes. OXPHOS inhibition led to a marked increase in the size and distribution of viral replication centers and accelerated the production and release of infectious particles, occurring ∼2 hours earlier than in parental A549-ACE2 (wild type) cells. Subsequently, we found that increased glycolytic capacity was required for enhanced viral replication whereas differences in innate immune pathway activation were not. Reintroduction of mtDNA from a well-defined maternal lineage into the ρ 0 cells reinstated OXPHOS, impaired SARS-CoV-2 replication, and reversed associated viral and glycolytic correlates. Thus, metabolic balance regulates SARS-CoV-2 replication, with OXPHOS exerting an antiviral effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus ReplicationOxidative PhosphorylationMitochondriaSARS-CoV-2COVID-19HumansDNA, MitochondrialA549 CellsGlycolysisAngiotensin-Converting Enzyme 2

Substanzen

DNA, MitochondrialAngiotensin-Converting Enzyme 2ACE2 protein, human

Autor:innen und Institutionen

  • Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Virology, Immunology and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Department of Pathology and Laboratory medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.

ORCID-Profile: Yentli E Soto Albrecht, Devin Kenney, Arnold Z Olali, Alan Wacquiez, Nader Chehadeh, Zimu Cen, Ian Chen, Gabrielle A Widjaja, Alessia Angelin, Wanqing Xie, Prasanth Potluri, Marie T Lott, Shiping Zhang, Mohsan Saeed, Deborah G Murdock, Susan R Weiss, Florian Douam, Douglas C Wallace

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • U.S. Department of Defense
  • Bill and Melinda Gates Foundation
  • Boston University
  • Boston University NEIDL Startup
  • T32 training grant in immunology

Zitieren

APA

Soto Albrecht, Y. E., Morrow, R. M., Kenney, D., Olali, A. Z., Wacquiez, A., Chehadeh, N., Cen, Z., Haltom, J. A., Chen, I., Ranshing, S. S., Widjaja, G. A., Angelin, A., Tintos-Hernandez, J. A., Xie, W., Potluri, P., Lott, M. T., Zhang, S., Saeed, M., Murdock, D. G., …, & Wallace, D. C. (2026). Mitochondrial OXPHOS restricts SARS-CoV-2 replication. Science Advances, 12(23). https://doi.org/10.1126/sciadv.adz3081

Vancouver

Soto Albrecht YE, Morrow RM, Kenney D, Olali AZ, Wacquiez A, Chehadeh N, et al. Mitochondrial OXPHOS restricts SARS-CoV-2 replication. Science Advances. 2026;12(23). doi:10.1126/sciadv.adz3081

BibTeX
@article{SotoAlbrecht2026,
  author = {Soto Albrecht, Yentli E and Morrow, Ryan M and Kenney, Devin and Olali, Arnold Z and Wacquiez, Alan and Chehadeh, Nader and Cen, Zimu and Haltom, Jeffrey A and Chen, Ian and Ranshing, Sujata S and Widjaja, Gabrielle A and Angelin, Alessia and Tintos-Hernandez, Jesus A and Xie, Wanqing and Potluri, Prasanth and Lott, Marie T and Zhang, Shiping and Saeed, Mohsan and Murdock, Deborah G and Weiss, Susan R and Douam, Florian and Wallace, Douglas C},
  title = {Mitochondrial OXPHOS restricts SARS-CoV-2 replication},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {23},
  doi = {10.1126/sciadv.adz3081}
}
Kostenlos starten →